These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1748507)

  • 1. Adverse events following immunization: 1990.
    Sokhey J
    Indian Pediatr; 1991 Jun; 28(6):593-607. PubMed ID: 1748507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary immunization of premature infants with gestational age <35 weeks: cardiorespiratory complications and C-reactive protein responses associated with administration of single and multiple separate vaccines simultaneously.
    Pourcyrous M; Korones SB; Arheart KL; Bada HS
    J Pediatr; 2007 Aug; 151(2):167-72. PubMed ID: 17643770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following immunization with DTP vaccine.
    Stetler HC; Mullen JR; Brennan JP; Orenstein WA; Bart KJ; Hinman AR
    Dev Biol Stand; 1985; 61():411-21. PubMed ID: 3879686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National programme for the control of poliomyelitis.
    Sokhey J
    Indian J Public Health; 1985; 29(3):168-74. PubMed ID: 3835134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety monitoring in vaccine development and immunization.
    Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
    Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse events following immunization: AEFI in 17 children between 0 and 2 years of age].
    Taraszkiewicz F; Bogus-Parafieniuk W; Ołdak E; Sulik A
    Przegl Epidemiol; 1994; 48(4):505-9. PubMed ID: 7597191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse reactions to diphtheria-pertussis-tetanus vaccine in the Chilean Immunization Program].
    Abarca V K; Cerda L J; Ferreccio R C
    Rev Med Chil; 2009 Jan; 137(1):10-7. PubMed ID: 19399316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey to establish the incidence of minor side effects in infants following protective immunization.
    Floyd CB; Freeling P
    J R Coll Gen Pract; 1989 Sep; 39(326):359-63. PubMed ID: 2558185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine immunizations and adverse events in infants with single-ventricle physiology.
    McAlvin B; Clabby ML; Kirshbom PM; Kanter KR; Kogon BE; Mahle WT
    Ann Thorac Surg; 2007 Oct; 84(4):1316-9. PubMed ID: 17888989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postmarketing surveillance of secondary effects of vaccines].
    Duclos P
    Rev Epidemiol Sante Publique; 1994; 42(5):425-33. PubMed ID: 7973002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of neonatal tetanus in India.
    Sokhey J; Bhargava I
    Indian Pediatr; 1984 Jul; 21(7):515-9. PubMed ID: 6519778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse events following vaccination reported to the Netherlands Pharmacovigilance Center Lareb in 2004-2006].
    Labadie J; van Grootheest AC
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2738-42. PubMed ID: 18225798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New recommended schedule for active immunization of normal infants and children.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Sep; 35(37):577-9. PubMed ID: 3092014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.